Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:651 (18 September), doi:10.1136/bmj.38210.827917.7C (published 10 September 2004)
Birgit K van Staaij, general practitioner1, Emma H van den Akker, otorhinolaryngologist2, Maroeska M Rovers, clinical epidemiologist1, Gerrit Jan Hordijk, professor3, Arno W Hoes, professor1, Anne G M Schilder, otorhinolaryngologist2
1 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85060, 3508 AB Utrecht, Netherlands, 2 Department of Otorhinolaryngology, Wilhelmina Children's Hospital, University Medical Center Utrecht, PO Box 85090, 3508 AB Utrecht, Netherlands, 3 Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, 3584 CX Utrecht, Netherlands
Correspondence to: A G M Schilder A.Schilder{at}wkz.azu.nl
Design Open, randomised controlled trial.
Setting 21 general hospitals and three academic centres in the Netherlands.
Participants 300 children aged 2-8 years requiring adenotonsillectomy.
Intervention Adenotonsillectomy compared with watchful waiting.
Main outcome measures Episodes of fever, throat infections, upper respiratory tract infections, and health related quality of life.
Results During the median follow up period of 22 months, children in the adenotonsillectomy group had 2.97 episodes of fever per person year compared with 3.18 in the watchful waiting group (difference -0.21, 95% confidence interval -0.54 to 0.12), 0.56 throat infections per person year compared with 0.77 (-0.21, -0.36 to -0.06), and 5.47 upper respiratory tract infections per person year compared with 6.00 (-0.53, -0.97 to -0.08). No clinically relevant differences were found for health related quality of life. Adenotonsillectomy was more effective in children with a history of three to six throat infections than in those with none to two. 12 children had surgery related complications.
Conclusion Adenotonsillectomy in children with mild symptoms of throat infections or adenotonsillar hypertrophy has no major clinical benefits over watchful waiting.
We excluded children with a history of seven or more throat infections in the preceding year, with five or more in each of the previous two years, or with three or more in each of the previous three years,1 and children with suspected obstructive sleep apnoea (Brouillette's obstructive sleep apnoea score > 3.5).12 Other exclusion criteria were Down's syndrome, craniofacial malformations, and immunodeficiency, other than that of IgA or IgG2.
Randomisation
Children were randomly assigned to either adenotonsillectomy or watchful waiting according to a computer generated list. At entry to the study, a disease specific questionnaire was completed for information on the number of throat infections and upper respiratory tract infections experienced by the children in the previous year; obstructive symptoms during sleep12; eating patterns; ear, nose, and throat operations; and risk factors for upper respiratory tract infections.
The parents completed two generic health related quality of life instruments: the TNO-AZL preschool children quality of life questionnaire and the child health questionnaire parental form.13 14 The children underwent an ear, nose, and throat examination and had their length and weight measured.
Follow up
The parents kept a diary of upper respiratory tract infections in their child. Absences from day care or school due to upper respiratory tract infections were also noted. The children's temperature was measured daily with a validated tympanic membrane thermometer15; an inbuilt device stored the date and first measurement of each day. The study doctors collected all data during follow up visits at 3, 6, 12, 18, and 24 months. At these visits, the questionnaires were again completed. An ear, nose, and throat examination was carried out, and length and weight were measured.
Primary and secondary outcomes
Our primary outcome was the incidence of fever (
38.0°C for at least one day), measured in number of episodes and days. An episode was considered finished when at least one day was without fever. New episodes were those occurring after a fever free interval of at least seven days.
Secondary outcomes were throat infections (sore throat with fever), number of episodes and days of sore throat, upper respiratory tract infections, absence from day care or school due to upper respiratory tract infections, health related quality of life, patterns of sleep and eating, length, and weight. Throat infections, sore throats, and upper respiratory tract infections were measured in episodes and days. We also included sore throats and upper respiratory tract infections immediately after adenotonsillectomy.
Statistical analysis
Our sample size calculation was based on a clinically relevant reduction of fever episodes and throat infections after adenotonsillectomy of 25% (see bmj.com). We calculated the effects of adenotonsillectomy on fever, throat infections, and upper respiratory tract infections as differences in incidence and incidence rate ratios per person year, with 95% confidence intervals. We used
2 tests and Student's t tests to evaluate differences in percentages and mean values between the groups. We used the Bonferroni correction to adjust for multiple testing and the Mantel-Haenzel test to adjust for potential confounders. As the estimates of effect were not influenced by these adjustments, we present the estimates of crude effect.
To detect possible modification from effects, we carried out subgroup analyses according to the burden of upper respiratory tract symptoms in the year before entry to the trial and age. We analysed interactions with Poisson regression. All analyses were performed on an intention to treat basis.
Children in the adenotonsillectomy group had 0.21 fewer episodes of fever (95% confidence interval -0.12 to 0.54) per person year (table 1). During the first six months of follow up, the number of episodes was lower in children in the adenotonsillectomy group (see bmj.com). From six to 24 months there was no difference between the groups.
|
Compared with the watchful waiting group, children in the adenotonsillectomy group had, per person year, fewer throat infections (0.21, 95% confidence interval 0.06 to 0.36), fewer sore throats (0.60, 0.30 to 0.90), fewer days with sore throat (5.91, 5.24 to 6.57), and fewer upper respiratory tract infections (0.53, 0.08 to 0.97; see table 1).
Absence from day care or school due to upper tract respiratory infections was comparable between the groups (difference 0.09, -0.27 to 0.44).
At six months, small significant differences were found for some domains of the health related quality of life questionnaires, but these were not clinically relevant (see bmj.com). We found no differences in other domains and at 24 months.
At six months, Brouillette's scores were lower for children in the adenotonsillectomy group (see bmj.com). At 24 months there was no difference between the groups. Similarly, at six months, fewer children in the adenotonsillectomy group experienced snoring and difficulties in eating, whereas there were no differences at 24 months (data not shown). Length and weight of children in both groups remained similar (data not shown).
The effects of adenotonsillectomy were more pronounced in children with three to six throat infections in the year before entry to the trial than in those with none to two throat infections: fever episodes (differences -1.07, 95% confidence interval -1.59 to -0.56 v 0.34, -0.08 to 0.77, P = 0.01; table 2) and days with sore throat per person year (differences -11.33, -12.48 to -10.17 v -2.38, -3.19 to -1.60, P = 0.01). Age had no effect.
|
Of the 195 children who underwent adenotonsillectomy (50 in the watchful waiting group), 12 (6%) had surgery related complications; 7 (4%) had a primary haemorrhage and five (3%) had postoperative nausea.
During the first six months of follow up the incidence of fever was significantly lower in the adenotonsillectomy group than in the watchful waiting group, but was the same from six to 24 months. Sleep and eating patterns initially improved more in children in the adenotonsillectomy group, but by 24 months the differences had disappeared.
Possible limitations
Our trial has several limitations. Firstly, our results are generalisable only to children with mild symptoms of throat infections or adenotonsillar hypertrophy as we excluded children with frequent throat infections or obstructive sleep apnoea, which are generally considered adequate for surgery.
Secondly, 50 children (34%) changed from watchful waiting to surgery. Per protocol analyses that exclude children who change groups will underestimate the effect of treatment. Conversely, analysing children on the basis of time spent in a treatment arm might overestimate or underestimate this effect. For these reasons we chose an intention to treat analysis.
|
Thirdly, we measured health related quality of life with generic questionnaires because disease specific instruments for children with tonsil and adenoid disease were not available when we started our study.16 We chose the TAPQoL and TACQoL preschool children quality of life questionnaires because they include relevant domains.13
Finally, not all eligible children entered the trial. In an earlier study, however, we showed that there were no major differences between included children and those who were eligible but not included.17
Strengths of the study
The major strength of our study is the inclusion of the objective primary outcome of fever measured daily by a validated thermometer that automatically stored data.15 Fever is an important physical sign in many diseases of children, and most episodes of fever in children under 8 years of age are caused by upper respiratory tract infections.18
19 We found that adenotonsillectomy did not significantly reduce the number of fever episodes but did have a small but statistically significant effect on the number of throat infections.
The power of our study was large enough to allow for subgroup analyses, providing a tool for clinicians to identify children that are likely to benefit from adenotonsillectomy.
This is the abridged version of an article that was posted on bmj.com on 10 September 2004: http://bmj.com/cgi/doi/10.1136/bmj.38210.827917.7C
We thank the participants and their parents; our colleagues and nurses in the participating hospitals; Nelly van Eden for secretarial support; Patrick Poels, Ward Videler, Charlotte van Krevel, and Wytske Richard for help with the conduct of the trial and recruitment of the patients; and Frank Leus for data management.
Funding: Dutch Health Care Insurance Board (OG-99-060).
Competing interests: None declared.
Ethical approval: This study was approved by the medical ethics committees of all participating hospitals.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses